risedronic acid has been researched along with Bowel Diseases, Inflammatory in 3 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kriel, MH | 1 |
| Tobias, JH | 1 |
| Creed, TJ | 1 |
| Lockett, M | 1 |
| Linehan, J | 1 |
| Bell, A | 1 |
| Przemioslo, R | 1 |
| Smithson, JE | 1 |
| Brooklyn, TN | 1 |
| Fraser, WD | 1 |
| Probert, CS | 1 |
| Palomba, S | 1 |
| Orio, F | 1 |
| Manguso, F | 1 |
| Falbo, A | 1 |
| Russo, T | 1 |
| Tolino, A | 1 |
| Tauchmanovà, L | 1 |
| Colao, A | 1 |
| Doldo, P | 1 |
| Mastrantonio, P | 1 |
| Zullo, F | 1 |
| Henderson, S | 1 |
| Hoffman, N | 1 |
| Prince, R | 1 |
3 trials available for risedronic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Drug Administration S | 2010 |
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.
Topics: Bone Density; Bone Density Conservation Agents; Etidronic Acid; Female; Femur; Femur Neck; Humans; I | 2005 |
A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adult; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; | 2006 |